Oracle Investment Management as of Dec. 31, 2023
Portfolio Holdings for Oracle Investment Management
Oracle Investment Management holds 26 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biohaven (BHVN) | 18.6 | $31M | 716k | 42.80 | |
| Pacific Biosciences Calif In Call Call Option | 10.7 | $18M | 1.8M | 9.81 | |
| Teladoc Health Call Call Option | 8.4 | $14M | 640k | 21.55 | |
| Pacific Biosciences of California (PACB) | 8.2 | $14M | 1.4M | 9.81 | |
| Quidel Corp (QDEL) | 7.9 | $13M | 177k | 73.70 | |
| Quidelortho Corp Call Call Option | 7.7 | $13M | 172k | 73.70 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 5.6 | $9.3M | 402k | 23.11 | |
| Springworks Therapeutics Call Call Option | 5.5 | $9.1M | 250k | 36.50 | |
| Ardelyx Call Call Option | 5.4 | $8.8M | 1.4M | 6.20 | |
| Springworks Therapeutics (SWTX) | 3.5 | $5.7M | 157k | 36.50 | |
| Ardelyx (ARDX) | 3.3 | $5.4M | 865k | 6.20 | |
| Eyepoint Pharmaceuticals Call Call Option | 3.1 | $5.1M | 220k | 23.11 | |
| Forian Ord (FORA) | 2.4 | $4.0M | 1.4M | 2.92 | |
| Biohaven Call Call Option | 2.0 | $3.2M | 75k | 42.80 | |
| BioCryst Pharmaceuticals (BCRX) | 2.0 | $3.2M | 536k | 5.99 | |
| Walgreens Boots Alliance Call Call Option | 1.6 | $2.6M | 100k | 26.11 | |
| Teladoc (TDOC) | 1.5 | $2.4M | 113k | 21.55 | |
| Immutep Sponsored Ads (IMMP) | 0.8 | $1.2M | 516k | 2.40 | |
| Agenus Com New (AGEN) | 0.7 | $1.2M | 1.4M | 0.83 | |
| Biogen Idec (BIIB) | 0.4 | $624k | 2.4k | 258.77 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.3 | $491k | 178k | 2.75 | |
| Accelerate Diagnostics Com New (AXDX) | 0.3 | $437k | 112k | 3.92 | |
| Vertex Energy (VTNR) | 0.1 | $170k | 50k | 3.39 | |
| Biodesix (BDSX) | 0.1 | $112k | 61k | 1.84 | |
| Dermtech Ord ord (DMTK) | 0.1 | $84k | 48k | 1.75 | |
| Mink Therapeutics (INKT) | 0.0 | $40k | 37k | 1.07 |
